Ohio State University is a clinical research site located in Hilliard, Ohio, United States 43026.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Ohio State University has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Endometrial Adenocarcinoma, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate.
Sponsors: Acrivon Therapeutics, Eli Lilly and Company.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ohio State University has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ohio State University has 3 clinical trials on record, with 3 currently active. Their work covers Endometrial Adenocarcinoma, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate.
Ohio State University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.